Tamarly Intelligence
Company · ILMN (Nasdaq)

Illumina, Inc.

Laboratory Analytical Instruments

Key figures
Revenue, 2025
$4.34B
Employees
9,250
Industry
Laboratory Analytical Instruments (SIC 3826)
Institutional holders
935 at 30 Jun 2026 (849 the quarter before)
SEC number
1110803
LEI
SQ95QG8SR5Q56LSNF682

Source: SEC EDGAR filings and company facts, SEC Form 13F; checked 27 Oct 2026

About

Illumina, Inc. is an American company that develops systems for the analysis of genetic variation in biotechnology, headquartered in San Diego, founded in 1998.

Source: Wikidata

Latest filings
13 Oct 2026
8-K 8-K
17 Aug 2026
8-K 8-K
13 Aug 2026
8-K CURRENT REPORT
12 Aug 2026
8-K 8-K
7 Aug 2026
8-K 8-K

Source: SEC EDGAR

With a free account

A free account opens 10 full pages a month and lets you follow this page: 12 quarters of figures, every filing and document, earnings call transcripts, holders and ownership changes, the Brain's cards and graph, exports to Excel.

Start freeSign in

Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.

Illumina, Inc.: Revenue $4.34B (2025), filings, holders and country risk | Tamarly